Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer

Key facts

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Principal Investigator

Philippe Lambin, MD, MD

Maastricht University Medical Center

Intervention

epoetin alfa(biological)

Enrollment

47 enrolled

Eligibility

18-75 years · All sexes

Timeline

2001

Study locations (15)

• Newcastle Mater Misericordiae Hospital, Newcastle, New South Wales, Australia
• Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
• Institut Jules Bordet, Brussels (Bruxelles), Belgium
• Cliniques Universitaires Saint-Luc, Brussels (Bruxelles), Belgium
• Hopital de Jolimont, Haine-Saint-Paul, Belgium
• U.Z. Gasthuisberg, Leuven, Belgium
• Clinique Sainte Elisabeth, Namur, Belgium
• Institut Gustave Roussy, Villejuif, France
• Universitaetsklinikum Charite, Berlin, Germany
• Radius Hungaricus Oncology Group, Törökbálint, Hungary
• Rambam Medical Center, Haifa, Israel
• Radiotherapeutisch Instituut Limburg, Heerlen, Netherlands
• Hospital de la Santa Cruz I Sant Pau, Barcelona, Spain
• Ospedale San Giovanni, Bellinzona, Switzerland
• Beatson Oncology Centre, Glasgow, Scotland, United Kingdom

Collaborators

Trans Tasman Radiation Oncology Group · Charite University, Berlin, Germany · Groupe Oncologie Radiotherapie Tete et Cou · Radius Hungaricus Oncology Group · Grup per l'Estudi dels Limfomes de Catalunya i Balears

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07195734
  Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  National Cancer Institute (NCI)
• RECRUITINGNANCT07264036
  Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
  Vanessa Torrecillas
• RECRUITINGPHASE2NCT07121595
  Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
  University of Michigan Rogel Cancer Center
• RECRUITINGNCT05837221
  Microbiome in Head and Neck Squamous Cell Carcinoma
  University of Colorado, Denver
• RECRUITINGPHASE2NCT05576974
  A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
  University of Texas Southwestern Medical Center
• RECRUITINGPHASE1, PHASE2NCT06265025
  GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
  GeneMedicine Co., Ltd.
• RECRUITINGNANCT05811936
  The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
  Medical University of South Carolina
• ACTIVE NOT RECRUITINGPHASE1NCT05820711
  Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
  University of Wisconsin, Madison

See all trials for Squamous cell carcinoma of oral cavity and lip →